Dr. Currier studies the effectiveness of various treatment strategies for HIV in specific populations, including breastfeeding women and young mothers. He also explores the social determinants of health that affect cancer beliefs and vaccination rates among different demographic groups. His research aims to develop actionable solutions that enhance treatment adherence and health education, tailoring approaches to meet the unique needs of diverse communities.
Key findings
Switching to long-acting HIV treatment for breastfeeding mothers in Zimbabwe can decrease the risk of HIV transmission to infants from 7.49% to 6.58%.
The introduction of standardized definitions for HIV treatment failure led to clarity among 386 healthcare professionals, potentially improving patient management worldwide.
Among Oregonians surveyed, Asian and Pacific Islander participants were 2.5 times more likely to believe cancer risk is lifestyle-related, illustrating the need for targeted cancer education.
The use of pitavastatin in HIV patients resulted in a 24.3% increase in a protein important for heart health, suggesting it may stabilize heart plaque.
Only 19% of new mothers aged 18-26 accepted the HPV vaccination postpartum, highlighting significant barriers related to language and healthcare provider influence.
Frequently asked questions
Does Dr. Currier study HIV treatments for breastfeeding mothers?
Yes, he researches long-acting HIV treatments to help breastfeeding women manage their condition effectively.
What community health issues does Dr. Currier address?
He focuses on health disparities in cancer awareness and treatment accessibility, particularly among Asian, Pacific Islander, Hispanic, and Latino communities.
Is Dr. Currier’s work relevant to young mothers?
Absolutely, his research includes studying HPV vaccination rates among new mothers and how various factors influence their decisions.
What impact has Dr. Currier's research had on healthcare practices?
His recommendations and findings, such as standardized definitions for treatment failure, are set to improve both patient management and health outcomes globally.
How does Dr. Currier's research help patients with complex health needs?
His studies on community paramedicine have shown significant reductions in unnecessary emergency room visits for patients with complex medical conditions.
Publications in plain English
Long-Acting Antiretroviral Therapy for Breastfeeding Women With HIV Experiencing Barriers to Adherence in Zimbabwe: Modeling Clinical Impact and Cost-effectiveness.
2026
The Journal of infectious diseases
Tewari SE, Hoffman R, Lockman S, Flanagan CF, Webb KA +14 more
Plain English This study examined how a long-acting HIV treatment (LA-ART) could help breastfeeding mothers in Zimbabwe who struggle to consistently take their medication. Researchers found that LA-ART could prevent more HIV infections in infants, lowering the risk from 7.49% to 6.58% for mothers who started without viral suppression, while also slightly increasing the expected lifespan of children. The findings show that switching to LA-ART can be a beneficial strategy, with an estimated cost-effectiveness threshold for some groups being as low as $84 per year.
Who this helps: This research helps breastfeeding mothers with HIV and their infants.
Predictors of Human Papillomavirus Vaccination in the Postpartum Period for Individuals Aged 18-26.
2025
Journal of women's health (2002)
Nguyen CGT, Mandelbaum A, Ward L, Bolten K, Yanit K +2 more
Plain English This study looked at the rates of HPV vaccination among new mothers aged 18-26 after they gave birth. Out of 1,130 eligible patients, only 19% accepted the vaccine. Factors that influenced their decision included language preference, tobacco use, and the type of healthcare provider who delivered their baby; for example, Spanish speakers were over five times more likely to accept the vaccine than English speakers. This matters because understanding these factors can help healthcare providers encourage more young mothers to get vaccinated during the postpartum period.
Who this helps: New mothers and healthcare providers.
Pitavastatin, Procollagen Pathways, and Plaque Stabilization in Patients With HIV: A Secondary Analysis of the REPRIEVE Randomized Clinical Trial.
2025
JAMA cardiology
Kolossváry M, Schnittman SR, Zanni MV, Fitch KV, Fichtenbaum CJ +19 more
Plain English This research studied how the drug pitavastatin affects heart plaque in patients living with HIV. The findings revealed that pitavastatin significantly increased levels of a protein called PCOLCE, which is important for collagen production, resulting in a 24.3% increase. This is significant because it indicates that pitavastatin can help stabilize fragile heart plaques, potentially reducing the risk of heart issues for these patients.
Who this helps: This benefits patients living with HIV who are at risk for cardiovascular disease.
Identifying Sociodemographic Disparities in Negative Cancer Beliefs and Health-Information-Seeking Attitudes Among Oregonians.
2025
Cancer control : journal of the Moffitt Cancer Center
Feng S, Li J, Currier J, Farris PE, Sellers T +2 more
Plain English This study looked at how different racial and socioeconomic groups in Oregon view cancer risks and their willingness to seek health information. Researchers surveyed 1,357 adults and found that Asian and Pacific Islander participants were significantly more likely to believe cancer is caused by lifestyle choices (2.5 times more), doubt they can prevent cancer (2.8 times more), and link cancer with death (1.6 times more) compared to Non-Hispanic Whites. This is important because it highlights the need for tailored health education that addresses these negative beliefs, which can impact cancer screening and outcomes.
Who this helps: This helps patients, particularly those from Asian and Pacific Islander backgrounds, by improving how health information is communicated to them.
Establishing shared definitions of virological failure and discontinuation for long-acting injectable cabotegravir and rilpivirine therapy (the CONSENSUS-LAI Study): an international survey and Delphi process.
2025
The lancet. HIV
Orkin C, Paterson A, Elias A, Smuk M, Ring K +49 more
Plain English The CONSENSUS-LAI study looked at how doctors define when long-acting injectable treatments for HIV, specifically cabotegravir and rilpivirine, stop being effective or should be discontinued. Researchers gathered input from 386 healthcare professionals across 28 countries and worked with a panel of 52 experts. They agreed on clear definitions: virological failure is when a patient's viral load is above 200 copies per mL on two different tests or exceeds 1000 copies once, while treatment should be seen as discontinued if a patient misses two injections without taking oral medicines in between.
Who this helps: This benefits healthcare providers and patients receiving HIV treatment by establishing consistent guidelines for monitoring their health.
Abstracts of the 26th International Workshop on Clinical Pharmacology of HIV, Hepatitis and other Antiviral Drugs 2025, 3-4 September 2025, Amsterdam, the Netherlands.
2025
British journal of clinical pharmacology
Nerguizian D, Wei Z, Aldrovandi G, Currier J, Eron J +13 more
Building Social Support and Moral Healing on Nursing Units: Design and Implementation of a Culture Change Intervention.
2024
Behavioral sciences (Basel, Switzerland)
Usset TJ, Godzik C, Harris JI, Wurtz RM, Pyne JM +10 more
Plain English This study looked at a program called RECONN, aimed at improving social support and healing for nurses facing moral challenges in a medical intensive care unit. The research found that 70% of nurses found the program acceptable, and there were measurable improvements in social support and emotional recovery. This is important because it could help reduce burnout and improve the work environment for nurses, leading to better patient care overall.
Who this helps: This benefits nurses and ultimately leads to improved care for patients.
Lessons learned from COVID-19 to overcome challenges in conducting outpatient clinical trials to find safe and effective therapeutics for the next infectious pandemic.
2024
Journal of clinical and translational science
Oh MA, Currier J, Khan A, Mylonakis E, Newell M +5 more
Early antiviral CD4+ and CD8+ T cells are associated with upper airway clearance of SARS-CoV-2.
2024
JCI insight
Ramirez SI, Lopez PG, Faraji F, Parikh UM, Heaps A +17 more
Plain English This study looked at how certain T cells in the body help reduce levels of the SARS-CoV-2 virus in the upper respiratory tract of 95 unvaccinated individuals with COVID-19. Researchers found that most people showed a strong response from two types of T cells, CD4+ and CD8+, within just six days of showing symptoms, and this response was linked to lower virus levels, regardless of antibody levels. This is important because it highlights how T cells play a key role in helping the body fight off COVID-19 early on.
Who this helps: This helps patients with COVID-19, particularly those at high risk for severe disease.
Markers of Maternal Bone and Renal Toxicity Through 50 Weeks Postpartum: IMPAACT 2010 (VESTED) Trial.
2024
Journal of acquired immune deficiency syndromes (1999)
Masheto G, Brummel SS, Ziemba L, Shepherd J, Mbengeranwa T +20 more
Plain English This study looked at how different HIV treatments during pregnancy affected women's bone and kidney health up to 50 weeks after giving birth. It found that while women taking the dolutegravir + emtricitabine/tenofovir alafenamide (DTG + FTC/TAF) showed somewhat better bone health, overall, there were no significant differences in bone density or kidney function changes among the different treatment groups. This matters because understanding the long-term health impacts of these treatments helps ensure safer options for pregnant women with HIV.
Who this helps: This helps pregnant women with HIV and their healthcare providers.
Transfusing Convalescent Plasma as Post-Exposure Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Double-Blinded, Phase 2 Randomized, Controlled Trial.
2023
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Shoham S, Bloch EM, Casadevall A, Hanley D, Lau B +51 more
Plain English This study investigated whether convalescent plasma from people who recovered from COVID-19 could prevent infection in individuals who were recently exposed to the virus. It found that 14.8% of participants receiving convalescent plasma developed a COVID-19 infection, compared to 14.9% in the control group, showing that the plasma did not significantly reduce the risk of infection. These results are important because they indicate that using convalescent plasma as a preventive measure after exposure to COVID-19 may not be effective.
Who this helps: This helps patients who may be considering convalescent plasma as a treatment after exposure to COVID-19.
Cytomegalovirus Immunoglobulin G (IgG) Titer and Coronary Artery Disease in People With Human Immunodeficiency Virus (HIV).
2023
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Schnittman SR, Lu MT, Mayrhofer T, Burdo TH, Fitch KV +17 more
Plain English This study looked at whether the level of a specific antibody (called CMV IgG) linked to cytomegalovirus infection is connected to heart-related health issues in people living with HIV. Out of 672 participants, researchers found that while higher levels of CMV IgG were linked to some signs of inflammation, they did not find any significant relationship between these antibody levels and the presence of heart artery plaque or other heart disease indicators. This matters because understanding these connections could help manage heart health risks in people with HIV.
Who this helps: This helps patients living with HIV by providing insights into their heart health risks.
Self-reported Antiretroviral Adherence: Association With Maternal Viral Load Suppression in Postpartum Women Living With HIV-1 From Promoting Maternal and Infant Survival Everywhere, a Randomized Controlled Trial in Sub-Saharan Africa and India.
2023
Journal of acquired immune deficiency syndromes (1999)
Nevrekar N, Butler K, Shapiro DE, Atuhaire P, Taha TE +11 more
Plain English This study looked at how well new mothers living with HIV-1 followed their prescribed antiretroviral therapy (ART) and how that affected their viral load (the amount of virus in their blood). Researchers found that only 66% of mothers taking ART reported they missed no doses in the last month, compared to 83% of mothers giving their infants a preventive treatment. High viral loads (over 400 copies/mL) were more common when mothers missed doses, highlighting the importance of strict adherence to ART to ensure both maternal and infant health.
Who this helps: This information benefits new mothers with HIV, as well as healthcare providers working to improve treatment adherence.
Hydroxychloroquine for pre-exposure prophylaxis of COVID-19 in health care workers: a randomized, multicenter, placebo-controlled trial Healthcare Worker Exposure Response and Outcomes of Hydroxychloroquine (HERO-HCQ).
2023
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Naggie S, Milstone A, Castro M, Collins SP, Lakshmi S +19 more
Plain English This study investigated whether hydroxychloroquine (HCQ) could effectively prevent COVID-19 infections in healthcare workers, enrolling 1,360 participants. After 30 days, 6.0% of those taking HCQ and 7.8% of those taking a placebo developed confirmed or suspected COVID-19, indicating no significant difference in effectiveness. This matters because it shows that HCQ did not provide any notable benefit in preventing COVID-19 infections among healthcare workers, despite being considered as a preventive measure.
Who this helps: This helps healthcare workers and the medical community in understanding the effectiveness of COVID-19 prevention options.
Symptom Duration and Resolution With Early Outpatient Treatment of Convalescent Plasma for Coronavirus Disease 2019: A Randomized Trial.
2023
The Journal of infectious diseases
Baksh SN, Heath SL, Fukuta Y, Shade D, Meisenberg B +21 more
Plain English This study looked at whether convalescent plasma (CCP), a treatment using blood from recovered COVID-19 patients, could help outpatients recover from symptoms faster. After 14 days, there was no significant difference in symptom resolution between patients who received CCP (70.8% still had symptoms) and those who received a placebo (71.6% still had symptoms). This matters because it shows that CCP does not lead to quicker recovery for COVID-19 outpatients in this setting.
Who this helps: This helps doctors understand that convalescent plasma may not be an effective treatment for speeding up recovery in outpatient COVID-19 cases.
The impact of parent treatment preference and other factors on recruitment: lessons learned from a paediatric epilepsy randomised controlled trial.
2023
Trials
Carter B, Bray L, Al-Najjar N, Piella AT, Tudur-Smith C +16 more
Plain English Researchers looked at how parents' preferences about treatment and other factors affected their willingness to enroll children in a trial for epilepsy medications. They discovered that many parents were hesitant to allow their children to participate due to their strong opinions about antiseizure medications. Specifically, the study found that despite efforts to involve parents and children in decision-making, they did not anticipate the level of reluctance around randomization, ultimately leading to challenges in recruiting enough participants for the trial's next phase.
Who this helps: This helps parents and caregivers of children with epilepsy by emphasizing the importance of understanding their treatment preferences in clinical trials.
Effect of host factors and COVID-19 infection on the humoral immune repertoire in treated HIV.
2023
JCI insight
Schnittman SR, Jung W, Fitch KV, Zanni MV, McCallum S +17 more
Plain English This study looked at how HIV and COVID-19 infections affect the body’s immune response in people living with HIV who are on treatment. Researchers found that those with COVID-19 showed a higher response to cytomegalovirus, suggesting ongoing inflammation, and that people with higher body weight and lower immune cell counts had stronger but potentially harmful responses to COVID-19. These findings are important because they help explain why people with HIV may struggle more during COVID-19, particularly if they are obese or have lower immune function.
Who this helps: This benefits patients with HIV, especially those facing COVID-19.
Changing Agendas on Sleep, Treatment and Learning in Epilepsy (CASTLE) Sleep-E: a protocol for a randomised controlled trial comparing an online behavioural sleep intervention with standard care in children with Rolandic epilepsy.
2023
BMJ open
Al-Najjar N, Bray L, Carter B, Castle AP, Collingwood A +20 more
Plain English This study looks at how a new online sleep program can help children with Rolandic epilepsy improve their sleep compared to standard care. Researchers will compare two groups of 110 children: one will receive usual care, while the other will get usual care plus the new online intervention. The goal is to find out if this approach is more effective and cost-efficient, as the previous method using in-person sessions was expensive and hard to scale.
Who this helps: This helps children with Rolandic epilepsy and their families by providing better sleep management options.
Represent: A community engagement roadmap to improve participant representation in cancer early detection research: An Oregon case study.
2023
Frontiers in public health
Currier J, Arteaga I, Turner-Uaandja H, Starling B, Pashayan N +3 more
Plain English This study looked at why Hispanic and Latino communities in Oregon participate less in cancer early detection research compared to their cancer rates. It found that only 18% of cancer cases in the U.S. affect these groups, yet they make up less than 10% of research participants. The research highlighted the lack of awareness about research opportunities, barriers to participation, and uncertainty about the benefits of involvement, leading to suggestions for better engagement methods.
Who this helps: This benefits Hispanic and Latino patients and their communities by improving research participation and ensuring their needs are addressed in cancer studies.
The importance of appropriate selection of clinical endpoints in outpatient COVID-19 clinical trials.
2023
Communications medicine
Thorlund K, Smith D, Linsell C, White N, Butler C +7 more
Plain English This study looked at how choosing the right goals, or endpoints, in COVID-19 clinical trials impacts the usefulness of the trial results. Researchers found that many trials were using endpoints that didn't align with what policymakers and healthcare providers needed. This mismatch made it hard to compare treatments effectively. Getting the endpoints right is important because it leads to better decision-making about COVID-19 treatments.
Who this helps: This helps patients and healthcare providers who rely on clear and effective COVID-19 treatment data.
The Community Research Liaison Model: Facilitating community-engaged research.
2023
Journal of clinical and translational science
Jäderholm C, Currier J, Brown K, Audett A, Campbell L +6 more
Plain English The Community Research Liaison Model (CRLM) was developed to improve partnerships between communities and researchers in Oregon, focusing on health concerns identified by the communities themselves. Since its launch, the model has engaged with nearly 300 community projects across 18 rural counties, enhancing collaboration and building trust. This matters because it leads to better health research that is directly relevant to the needs of these communities, helping to address health disparities.
Who this helps: This helps patients and communities in rural Oregon.
Community paramedicine in Central Oregon: A promising model to reduce non-urgent emergency department utilization among medically complex Medicaid beneficiaries.
2023
Journal of the American College of Emergency Physicians open
Currier J, Wallace N, Bigler K, O'Connor M, Farris P +1 more
Plain English This study looked at how community paramedicine can help people with complex medical needs who often visit the emergency room (ER) for non-urgent issues. In two rural counties in Central Oregon, researchers found that this approach led to a 13.9% drop in overall emergency visits and a 38.9% drop in avoidable visits among 102 Medicaid patients who frequently used ER services. This is important because it shows that providing care at home can help reduce unnecessary trips to the ER, saving costs and resources.
Who this helps: This benefits patients with complex medical conditions who often rely on emergency services.
REPRESENT recommendations: improving inclusion and trust in cancer early detection research.
2023
British journal of cancer
Brockhoven F, Raphael M, Currier J, Jäderholm C, Mody P +5 more
Plain English This research focuses on improving how cancer early detection studies include more diverse groups of people, particularly those from minority communities, who often aren’t represented. It presents twelve specific recommendations to build trust and ensure these groups are included in research, which can help address the disparities in cancer outcomes. For example, the strategies include long-term relationships, sharing resources, and improving communication. By following these recommendations, researchers can better serve all communities in cancer research.
Who this helps: This benefits patients, especially those from minoritized groups, by ensuring research reflects their needs.
Equitable implementation of lung cancer screening: avoiding its potential to mirror existing inequities among people who use tobacco.
2023
Cancer causes & control : CCC
Bilenduke E, Anderson S, Brenner A, Currier J, Eberth JM +9 more
Plain English This paper looks at how lung cancer screening can help reduce deaths from lung cancer but points out that not everyone has equal access to these screenings, especially among people who smoke and come from different backgrounds. The authors highlight that issues like health insurance, race, sexual orientation, mental health, and military status can affect who gets screened, and they recommend tailored outreach to engage at-risk communities. This matters because making screening more accessible could save lives and reduce disparities in lung cancer outcomes.
Who this helps: This helps patients, especially those with a history of smoking and from diverse communities.
Rural libraries implementing walking groups or walking groups plus civic engagement for walkability in rural communities: a comparative effectiveness trial study protocol.
2023
BMC public health
Perry CK, Seguin-Fowler R, Maddock JE, Lenstra N, Dieckmann NF +4 more
Plain English This study looks at how to get more rural residents to be active by comparing two types of walking programs: one that focuses just on walking and another that combines walking with community involvement. The researchers aim to enroll around 350-400 participants from 20 small towns to see if including civic activities makes people more active. These findings are important because increased physical activity can help reduce health issues like heart disease and cancer in these communities.
Who this helps: Rural residents looking to improve their health through increased physical activity.
Adipokines, Weight Gain and Metabolic and Inflammatory Markers After Antiretroviral Therapy Initiation: AIDS Clinical Trials Group (ACTG) A5260s.
2022
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Koethe JR, Moser C, Brown TT, Stein JH, Kelesidis T +3 more
Plain English This study looked at how certain fat-related proteins (leptin and adiponectin) and fat distribution in the body changed in people starting HIV treatment over 96 weeks. Researchers found that leptin levels rose by 22%, while adiponectin levels barely changed. More body fat, especially in the trunk and abdomen, was linked to higher insulin resistance and inflammation markers, indicating that increased leptin may lead to health issues like impaired glucose tolerance in people starting HIV therapy.
Who this helps: This information helps patients living with HIV who are starting treatment and their healthcare providers.
Evolution of the SARS-CoV-2 proteome in three dimensions (3D) during the first 6 months of the COVID-19 pandemic.
2022
Proteins
Lubin JH, Zardecki C, Dolan EM, Lu C, Shen Z +59 more
Plain English Researchers studied how the SARS-CoV-2 virus, which causes COVID-19, changed over the first six months of the pandemic by examining the three-dimensional structures of its proteins. They found that the virus's 29 proteins experienced significant amino acid changes, particularly in key areas that could affect how the virus functions and responds to treatments, with over 48,000 viral samples analyzed. This information is crucial for developing effective drugs and preparing for future outbreaks since understanding these changes helps identify potential weaknesses in the virus.
Who this helps: This research benefits patients and healthcare providers by improving treatment options and vaccine effectiveness.
A Coordinated Approach to Implementing Low-Dose CT Lung Cancer Screening in a Rural Community Hospital.
2022
Journal of the American College of Radiology : JACR
Currier J, Howes D, Cox C, Bertoldi M, Sharman K +5 more
Plain English This study looked at how a rural hospital in Oregon set up a low-dose CT lung cancer screening program to help reduce lung cancer deaths in a community with high rates of the disease. Over three years, the hospital performed 567 screenings, with a notable increase in the number of scans each year—nearly five times more between 2018 and 2019—and found lung cancer in about 2% of those scanned, primarily in early stages (stage I or II). This matters because early detection through screening can significantly improve survival rates, making it crucial for high-risk groups in the community.
Who this helps: This benefits patients at risk for lung cancer, especially smokers and individuals with a family history of the disease.
Proteomic Signature of Subclinical Coronary Artery Disease in People With HIV: Analysis of the REPRIEVE Mechanistic Substudy.
2022
The Journal of infectious diseases
Kolossváry M, deFilippi C, Lu MT, Zanni MV, Fulda ES +12 more
Plain English This study looked at how certain proteins in people with HIV relate to early signs of heart disease, specifically looking for coronary artery disease (CAD) before major symptoms appear. Researchers found that a protein called NRP1 was strongly linked to the presence of calcium buildup and plaque in the arteries, showing odds ratios of 5.1 and 2.9, respectively. This is important because it highlights specific proteins that could help identify heart disease risk in people with HIV, allowing for earlier interventions.
Who this helps: This helps patients with HIV and their doctors identify and manage heart disease risks more effectively.
HIV and women in the USA: what we know and where to go from here.
2021
Lancet (London, England)
Adimora AA, Ramirez C, Poteat T, Archin NM, Averitt D +4 more
Plain English This paper looks at the ongoing challenges and progress regarding HIV among women in the USA. While new HIV diagnoses have decreased overall, significant differences exist based on race and location, highlighting that some women are still at higher risk. The government aims to reduce new infections by 90% in the next decade, but to succeed, there needs to be more participation of women in research and improved access to healthcare and supportive services that empower women to manage their own health.
Who this helps: This benefits women at risk for HIV and the healthcare professionals supporting them.
Tobacco Exposure Is Associated With Extremely Low Polyethylene Oxidation in Total Knee Arthroplasty Components.
2021
Arthroplasty today
Kunkel ST, Moschetti WE, Werth P, Fillingham Y, Jevsevar D +4 more
Plain English This study looked at how tobacco use affects the wear and tear of knee replacement components made of polyethylene. Researchers found that patients who were current smokers had knee implants with little to no oxidation, while non-smokers showed signs of higher oxidation rates in their implants. Specifically, out of 18 patients studied, 6 smokers had minimal oxidation compared to none in the super-oxidizer group, indicating a strong link between smoking and polyethylene oxidation levels.
Who this helps: This information benefits patients considering knee replacements, as well as doctors in assessing the risks associated with smoking.
Cardiovascular Risk and Health Among People With Human Immunodeficiency Virus (HIV) Eligible for Primary Prevention: Insights From the REPRIEVE Trial.
2021
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Douglas PS, Umbleja T, Bloomfield GS, Fichtenbaum CJ, Zanni MV +16 more
Plain English The study looked at the cardiovascular (heart health) risks of people living with HIV, focusing on factors like lifestyle and medical treatment. Out of nearly 7,400 participants, the average risk for heart disease was relatively low at 4.5%, but only 0.3% had ideal health across all seven key lifestyle metrics evaluated, such as diet and physical activity. This indicates that while many have lower risk scores, overall heart health is poor among these individuals, highlighting the need for better lifestyle changes alongside traditional medical treatments.
Who this helps: This helps patients with HIV improve their heart health and overall well-being.
Assessment of Coronary Artery Disease With Computed Tomography Angiography and Inflammatory and Immune Activation Biomarkers Among Adults With HIV Eligible for Primary Cardiovascular Prevention.
2021
JAMA network open
Hoffmann U, Lu MT, Foldyna B, Zanni MV, Karady J +22 more
Plain English This study looked at heart disease in people with HIV who typically have a low to moderate risk of cardiovascular issues. Researchers found that nearly half of the 755 participants had some plaque buildup in their arteries, with 30% of those considered at very low risk. Important markers of inflammation and immune response were higher in those with plaque, indicating that even people with controlled HIV and low traditional heart disease risk can still have significant heart health concerns.
Who this helps: Patients with HIV and healthcare providers managing their cardiovascular health.
Management of High-Grade Coronary Artery Disease and Concomitant Glanzmann Thrombasthenia.
2021
JACC. Case reports
Truong KP, Zhang JJ, Shahid M, Goud A, Rosove M +3 more
Plain English This study looked at how to treat a patient with serious heart artery disease who also has a bleeding disorder called Glanzmann thrombasthenia. The researchers found that there are no existing guidelines for safely improving blood flow in such patients, highlighting the need for careful management. Understanding these complexities is important because it can help healthcare providers make better decisions for patients facing similar challenges.
Who this helps: This helps doctors and patients with heart disease and Glanzmann thrombasthenia.
Randomized controlled trial transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection.
2021
medRxiv : the preprint server for health sciences
Shoham S, Bloch EM, Casadevall A, Hanley D, Lau B +50 more
Plain English This study looked at whether convalescent plasma, which contains antibodies from people who have recovered from COVID-19, could prevent infection in individuals who were recently exposed to the virus but had not yet shown symptoms. The trial involved 180 participants, with 87 receiving the convalescent plasma and 93 receiving standard plasma. The results showed that about 14.8% of those who received convalescent plasma and 14.9% of the control group developed SARS-CoV-2 infections, indicating that the treatment did not effectively prevent infection.
Who this helps: This research is important for doctors and patients exploring options for preventing COVID-19 after exposure.
Efficacy and safety of dolutegravir with emtricitabine and tenofovir alafenamide fumarate or tenofovir disoproxil fumarate, and efavirenz, emtricitabine, and tenofovir disoproxil fumarate HIV antiretroviral therapy regimens started in pregnancy (IMPAACT 2010/VESTED): a multicentre, open-label, randomised, controlled, phase 3 trial.
2021
Lancet (London, England)
Lockman S, Brummel SS, Ziemba L, Stranix-Chibanda L, McCarthy K +27 more
Plain English This study looked at how effective and safe different HIV treatment combinations are for pregnant women starting therapy in their second trimester. The results showed that 98% of women on the dolutegravir-based treatments achieved viral suppression at delivery, compared to 91% on the efavirenz regimen, indicating that dolutegravir is a better option. Additionally, fewer complications during pregnancy occurred in the dolutegravir group, such as preterm births and neonatal deaths, making it a safer choice for mothers and babies.
Who this helps: This benefits pregnant women living with HIV and their infants.
A 38-Year-Old Man With Well Treated OSA on CPAP With Persistent Nocturnal Hypoxemia.
2020
Chest
Culpepper DJ, Hong D, Ryden A, Currier J, Tobis JM +2 more
Plain English This study looked at a 38-year-old man with sleep apnea who was using a CPAP machine and still experienced low oxygen levels at night despite his treatment. Initially, his apnea-hypopnea index was very high at 99 events per hour, but after treatment, it dropped significantly to 1.9 events per hour. This matters because even with effective sleep apnea treatment, some patients may continue to have low oxygen levels, which can affect their health.
Who this helps: This information helps doctors managing patients with sleep apnea.
Angiotensin Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use Among Outpatients Diagnosed With COVID-19.
2020
The American journal of cardiology
Bae DJ, Tehrani DM, Rabadia SV, Frost M, Parikh RV +12 more
Plain English This study looked at whether using certain heart medications called ACE inhibitors (ACEIs) or angiotensin II receptor blockers (ARBs) affected the hospital admission rates of patients diagnosed with COVID-19. Researchers found that out of 590 patients, there was no significant difference in the hospital admission rates between those using ACEIs/ARBs and those who weren't, with both groups having similar rates of serious outcomes such as ICU stays and mortality. This matters because it confirms that using these heart medications does not increase the risk of getting severely ill from COVID-19.
Who this helps: This helps patients with heart conditions who are concerned about their medication during a COVID-19 diagnosis.
Music Can Reduce the Need for Pharmacologic Conscious Sedation During Invasive Coronary Angiography.
2020
The Journal of invasive cardiology
Ebrahimi R, Shroyer AL, Dennis P, Currier J, Lendvai Wischik D
Plain English This study looked at how listening to music during invasive coronary angiography (ICA) affects patients' need for sedative medications like opiates and benzodiazepines, which are typically used to manage pain and anxiety. Among 72 patients, those who listened to music needed less sedation; 40% used the sedative compared to 62% in the control group, and the amount of a specific sedative called midazolam was reduced from 0.68 mg to 0.37 mg. This matters because it shows that music can effectively help manage pain and anxiety, potentially leading to lower medication use and fewer side effects for patients.
Who this helps: This research benefits patients undergoing invasive procedures by offering a non-drug option for anxiety and pain management.
Evolution of the SARS-CoV-2 proteome in three dimensions (3D) during the first six months of the COVID-19 pandemic.
2020
bioRxiv : the preprint server for biology
Lubin JH, Zardecki C, Dolan EM, Lu C, Shen Z +59 more
Plain English Researchers studied the changes in the structure of the SARS-CoV-2 virus during the first six months of the COVID-19 pandemic by examining over 48,000 virus samples. They found that most changes occurred on the surfaces of the virus proteins, with only a few affecting the protein cores. Understanding these changes is important because it can help in drug development and identifying mutations that might make the virus resistant to treatments.
Who this helps: This benefits patients and researchers working on COVID-19 treatments.
An Evidence-Based Walking Program in Oregon Communities: Step It Up! Survivors.
2020
Preventing chronic disease
Perry CK, Campbell LP, Currier J, Farris PE, Wenzel ES +5 more
Plain English The study focused on a walking program called Step It Up! Survivors, aiming to boost physical activity among cancer survivors in Oregon communities. It found that participants increased their activity levels and social connections, but some organizations faced difficulties in getting people to join and sticking to the guidelines. Overall, the program was mostly followed, with adherence rates between 64% and 88%, showing that with the right support, these programs can be successfully implemented.
Who this helps: This benefits cancer survivors looking to improve their health and connect with others.
Core Health Outcomes in Childhood Epilepsy (CHOICE): Development of a core outcome set using systematic review methods and a Delphi survey consensus.
2019
Epilepsia
Crudgington H, Rogers M, Bray L, Carter B, Currier J +9 more
Plain English This study aimed to create a standardized list of important health outcomes to measure in research involving children with rolandic epilepsy, a common form of epilepsy. Researchers reviewed existing studies and collected input from young patients, their parents, and professionals, ultimately agreeing on 39 key health outcomes to focus on. This is significant because having a clear set of outcomes will make research more consistent and relevant, leading to better treatments and care.
Who this helps: This benefits children with rolandic epilepsy, their families, and healthcare professionals involved in their care.
Slow Acceptance of Universal Antiretroviral Therapy (ART) Among Mothers Enrolled in IMPAACT PROMISE Studies Across the Globe.
2019
AIDS and behavior
Stranix-Chibanda L, Brummel S, Pilotto J, Mutambanengwe M, Chanaiwa V +29 more
Plain English This research looked at how quickly pregnant and postpartum women with HIV started taking universal antiretroviral therapy (ART) after being informed about its benefits. It found that one-third of the women initially chose not to start ART, needing more time to think about it, and it took six sessions to encourage 95% of them to begin treatment. This matters because it shows that education and support are essential for improving health outcomes for mothers and their babies.
Who this helps: This helps mothers with HIV and their healthcare providers.
Changes in the Fungal Marker β-D-Glucan After Antiretroviral Therapy and Association With Adiposity.
2019
Open forum infectious diseases
Dirajlal-Fargo S, Moser C, Rodriguez K, El-Kamari V, Funderburg NT +5 more
Plain English This study looked at the levels of a substance called β-D-glucan (BDG), which indicates fungal presence in the body, in people with HIV starting antiretroviral therapy (ART) over 96 weeks. Researchers found that BDG levels increased by about 57% during the treatment, regardless of the specific ART regimen used; importantly, higher BDG levels were linked to increased body fat, with trunk fat growing by 8% and total fat by 7%. These findings suggest that even with HIV treatment, there may still be ongoing gut-related issues that could lead to weight gain and other metabolic problems.
Who this helps: This helps patients with HIV by highlighting potential risks linked to ART and guiding better management of weight and health during treatment.
Jackilen Shannon Markella V Zanni Kathleen V Fitch Pamela S Douglas Carl J Fichtenbaum Judith A Aberg Steven K Grinspoon Gerald S Bloomfield Borek Foldyna
Physician data sourced from the
NPPES NPI Registry
.
Publication data from
PubMed
.
Plain-English summaries generated by AI.
Not medical advice.